Robert H Vonderheide Selected Research

Robert H Vonderheide Research Topics

Disease

125	Neoplasms (Cancer) 04/2024 - 01/2002
24	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 06/2012
18	Adenocarcinoma 02/2024 - 05/2013
12	Melanoma (Melanoma, Malignant) 01/2023 - 03/2003
11	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2005
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 11/2006
5	Carcinoma (Carcinomatosis) 11/2017 - 02/2004
4	Carcinogenesis 05/2014 - 02/2004
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2006
3	Mesothelioma 01/2020 - 03/2005
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 11/2006
3	Infections 01/2017 - 02/2007
3	Neuroblastoma 11/2009 - 03/2004
2	Fatigue 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Nausea 01/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 03/2005
2	Disease Progression 01/2018 - 12/2016
2	Neoplasm Metastasis (Metastasis) 01/2016 - 03/2003
2	Inflammation (Inflammations) 06/2012 - 04/2011
2	Human Influenza (Influenza) 01/2011 - 06/2003
2	Multiple Myeloma 01/2011 - 06/2003
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2011 - 09/2003
2	Pleural Effusion (Pleural Effusions) 04/2010 - 03/2005
2	Malignant Pleural Effusion 04/2010 - 03/2005
1	Vitamin D Deficiency 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Vomiting 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021

Drug/Important Bio-Agent (IBA)

22	AntigensIBA 01/2021 - 01/2002
14	Monoclonal AntibodiesIBA 02/2024 - 03/2007
14	VaccinesIBA 01/2022 - 03/2003
13	Peptides (Polypeptides)IBA 11/2023 - 01/2002
13	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2023 - 01/2002
12	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
12	AntibodiesIBA 02/2021 - 03/2003
10	CytokinesIBA 01/2022 - 09/2003
10	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2002
7	selicrelumabIBA 01/2021 - 03/2007
7	EnzymesIBA 01/2013 - 01/2002
6	NivolumabIBA 01/2022 - 01/2015
6	Neoplasm Antigens (Tumor Antigens)IBA 12/2008 - 01/2003
5	LigandsIBA 12/2021 - 01/2013
5	Gemcitabine FDA Link 01/2021 - 03/2011
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 03/2003
5	EpitopesIBA 08/2009 - 06/2002
4	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2003
4	pembrolizumabIBA 11/2018 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2016
3	IpilimumabIBA 01/2022 - 01/2015
3	Immunoglobulin G (IgG)IBA 02/2021 - 03/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2010
3	Maraviroc FDA Link 01/2019 - 07/2015
3	Chimeric Antigen ReceptorsIBA 01/2018 - 07/2015
3	Interferon-gamma (Interferon, gamma)IBA 12/2016 - 02/2007
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2013 - 02/2007
3	Cancer VaccinesIBA 05/2012 - 06/2004
3	SurvivinIBA 12/2008 - 03/2004
2	Transcription Factors (Transcription Factor)IBA 02/2024 - 01/2018
2	PlatinumIBA 01/2022 - 01/2021
2	sotigalimabIBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 12/2021 - 12/2017
2	Immunoglobulin M (IgM)IBA 02/2021 - 03/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
2	130-nm albumin-bound paclitaxelIBA 01/2021 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2013
2	PerforinIBA 01/2021 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2018
2	olaparibIBA 01/2021 - 01/2021
2	rucaparibIBA 01/2021 - 01/2018
2	Chemotactic FactorsIBA 01/2020 - 01/2013
2	ChemokinesIBA 01/2020 - 11/2017
2	Hormones (Hormone)IBA 01/2019 - 07/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 01/2013
2	InterferonsIBA 12/2016 - 11/2006
2	Daclizumab (Zenapax)FDA Link 05/2012 - 09/2009
2	Interferon-betaIBA 04/2010 - 11/2006
2	telomerase reverse transcriptase (540-548)IBA 12/2007 - 02/2004
2	AutoantigensIBA 11/2005 - 02/2004
2	HLA-A*02:01 antigenIBA 06/2003 - 06/2002
1	Guanosine Triphosphate (GTP)IBA 04/2024
1	Interferon Regulatory FactorsIBA 02/2024
1	KRASG12D inhibitor MRTX1133IBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2022
1	niraparibIBA 01/2022
1	3,3',4',5-tetrachlorosalicylanilideIBA 12/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	SteroidsIBA 01/2021

Therapy/Procedure

59	Immunotherapy 02/2024 - 01/2002
49	Therapeutics 04/2024 - 01/2002
17	Drug Therapy (Chemotherapy) 01/2023 - 09/2003
6	Hematopoietic Stem Cell Transplantation 01/2018 - 08/2009
4	Radiotherapy 01/2021 - 01/2018
3	Cell Transplantation 01/2022 - 09/2003
3	Adjuvant Chemotherapy 01/2021 - 04/2010
2	Stem Cell Transplantation 01/2011 - 08/2009
2	Intravenous Infusions 11/2010 - 09/2009